Professor Gonçalo Bernardes has been honoured for his ground-breaking contributions to chemical and cancer biology.
The European Federation for Medicinal Chemistry and Chemical Biology has recognised the Trinity Hall Fellow for his innovative research in chemistry and molecular medicine, citing in particular his work on directly targeting and degrading viral RNA, which opens new possibilities for drug discovery and medical treatments.
The first EFMC-WuXi AppTec Award for Excellence in Chemical Biology cites Bernardes’ remarkable research in developing a new strategy for ‘hijacking’ and degrading RNA, dubbed meCLICK-Seq.
The citation states: “His innovative research pursues key questions in chemistry and molecular medicine by using strategies that bridge disciplines and inspire the programmes of other researchers.”
Professor Bernardes said: “I am delighted for our research to be recognised by the Chemical Biology and Drug Development communities. This is a recognition of the hard and innovative work of my group’s students and postdocs over the years.”
The award will be presented at the EFMC International Symposium on Chemical Biology in Switzerland in November, 2023.
In related news researchers from Professor Gonçalo Bernardes’ lab recently published a paper outlining their development of the system that directly targets and degrades viral RNA and which can be adapted to fight many viruses including that which causes COVID-19
The research was published in ACS Central Science.
This is a version of an original story that appeared on the Department of Chemistry website.
Image courtesy of @ChemistryPhotography
